
Sign up to save your podcasts
Or
Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies.
Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.
They also discuss:
@Azeem
Further resources:
4.9
601601 ratings
Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies.
Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.
They also discuss:
@Azeem
Further resources:
1,829 Listeners
384 Listeners
1,014 Listeners
503 Listeners
190 Listeners
3,982 Listeners
1,403 Listeners
744 Listeners
1,253 Listeners
189 Listeners
170 Listeners
372 Listeners
257 Listeners
636 Listeners
122 Listeners
90 Listeners
441 Listeners
450 Listeners
30 Listeners
36 Listeners